Has Siddharth Wayangankar, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,326,067 in general payments to Siddharth Wayangankar, MD across 1,813 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Siddharth Wayangankar, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Siddharth Wayangankar, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Siddharth Wayangankar, MD

Interventional Cardiology · Jacksonville, FLNPI 1386804565

Payments from drug & device makers

$1,326,067in general payments, 2019–2025

Across 1,813 payments — averaging $731.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Edwards Lifesciences$570K
Medtronic$405K
Essential Medical, Inc.$112K
Arrow International, Inc.$69K
Abbott$68K
Abiomed$51K
plus $51K from 34 others

What the payments were for

Consulting fees$385,51933%
Speaking & faculty fees$558,48848%
Travel & lodging$168,68015%
Food & beverage$46,7994%
Education$10%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Edwards Lifesciences	659	$569,552
Medtronic(2 entities)	444	$404,877
Essential Medical, Inc.	7	$112,376
Arrow International, Inc.	24	$69,402
Abbott	261	$68,213
Abiomed	122	$50,859
W. L. Gore & Associates, Inc.	25	$22,548
Penumbra, Inc.	39	$10,952
Teleflex LLC	39	$9,938
Endovascular Engineering Inc.	2	$2,158
Boston Scientific	90	$2,091
Shockwave Medical, Inc	12	$415
Cardiovascular Systems Inc.	8	$385
Avinger Inc.	8	$294
Novartis	13	$265
Pfizer	9	$176
Angiodynamics, Inc.	2	$172
Corindus Inc.	1	$163
Contego Medical, Inc	1	$149
Surmodics, Inc.	1	$125
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	6	$120
Johnson & Johnson	7	$115
Janssen Scientific Affairs, LLC	1	$107
Acist Medical Systems, Inc.	4	$105
Amgen	5	$86
Bard Peripheral Vascular, Inc.	3	$62
E.r. Squibb & Sons, L.L.C.	3	$54
Cardiva Medical, Inc.	2	$41
AstraZeneca	2	$39
Bayer	2	$39
Merck	2	$37
Actelion Pharmaceuticals US, Inc.	1	$27
Inspiremd Ltd	1	$25
Alnylam Pharmaceuticals Inc.	1	$22
Esperion Therapeutics, Inc.	1	$20
Atricure, Inc.	1	$18
Terumo Medical Corporation	1	$17
Baxter Healthcare	1	$15
Jenavalve Technology, Inc.	1	$6
Cvrx, Inc.	1	$4

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Edwards SAPIEN 3 Transcatheter Heart Valve$472,332
CoreValve Evolut$396,226
MANTA$72,321
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$56,685
Impella$47,817
NAVITOR$22,718
Indigo System$8,970
SAPIEN 3 Ultra RESILIA$5,307
Emboshield NAV6 system$5,123
MitraClip$3,846
EMBOSHIELD NAV6$3,170
XIENCE V$3,000
PASCAL$1,512
EVOQUE$1,245
Indigo$1,231
GUIDELINER$1,096
COREVALVE EVOLUT R$846
3F$569
ClosureFast$554
HawkOne$553

How this compares

$1,326,067 in reported general payments places this provider in the 95th percentile of 623 interventional cardiology providers in Florida.

See all interventional cardiology providers in Florida →

Medicare billing

Part B allowed, 2024

$607,098

Medicare patients

1,657

Services billed

4,794

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	108	$1,013
Enoxaparin Sodium	18	$583
Atorvastatin Calcium	24	$189
Lisinopril	14	$76

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Jacksonville

Dominick AngiolilloJacksonville$4M
Ruby SatpathyJacksonville$1.8M
Sumant LambaJacksonville$862K
Yazan KhatibJacksonville$588K
Bharat GummadiJacksonville$339K
Salil PatelJacksonville$306K
Raguveer MurthyJacksonville$249K
Douglas SpriggsClearwater$3.2M
Rakesh PrashadOcala$3.1M
Aldo Martinez FleitesMiami Lakes$2.2M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →